Hikma Pharmaceuticals Plc (OP: HKMPF )

23.62 -1.45 (-5.78%)

Streaming Delayed Price Updated: 9:30 AM EST, Nov 11, 2024 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	115
Open	25.07
Bid (Size)	N/A (0)
Ask (Size)	N/A (0)
Prev. Close	25.07
Today's Range	23.62 - 23.62
52wk Range	21.28 - 26.50
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Shortage Relief: More Takeda's Vyvanse For ADHD On the Way As US Ramps Up Production

September 06, 2024

Increase in production of Takeda's ADHD drug Vyvanse, approved by DEA to address ongoing shortages both domestically and globally.

Via Benzinga

Jazz And Hikma Accused Of Delaying Sleep Disorder Generic Drug To Maintain High Prices

August 28, 2024

Jazz Pharmaceuticals and Hikma Pharmaceuticals will face trial over allegations of delaying a generic version of Xyrem, causing higher drug prices. Plaintiffs accuse Jazz of antitrust violations and...

Via Benzinga

Performance

YTD	+0.51%	+0.51%
1 Month	-5.78%	-5.78%
3 Month	-6.42%	-6.42%
6 Month	-5.24%	-5.24%
1 Year	+10.98%	+10.98%

More News

Drug Shortages in Focus: How FDA's Quest for New Methotrexate Suppliers Affects the Cancer Treatment Landscape

June 12, 2023

Via Benzinga

Week In Review: Ten Biggest 2022 China Biopharma Deals Worth $21.5 Billion

December 31, 2022

Via Talk Markets

Up On Bad News

March 22, 2022

Via Talk Markets

A Peek Into The Markets: US Stock Futures Mostly Higher; Crude Oil Rises Over 1%

September 27, 2021

Via Benzinga

Hikma Bolsters Injectable Portfolio With $375M Custopharm Acquisition

September 27, 2021

Via Benzinga

Wonder Products

June 02, 2021

Via Talk Markets

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.